Gökçe, ŞefikHerkiloğlu, DilşadÇevik, ÖzgeTuran, Volkan2022-09-252022-09-252023Gökçe, S., Herkiloğlu, D., Çevik, O. & Turan, V. (2023). Evaluation of intrafollicular syndecan 1, glypican 3, and spermidine levels in women with diminished ovarian reserve. Reproductive Sciences, 30(2), pp. 569-575. https://doi.org/10.1007/s43032-022-01085-9https://doi.org/10.1007/s43032-022-01085-9https://hdl.handle.net/20.500.13055/273We aimed to evaluate the levels of Spermidine, Syndecan 1, and Glypican 3 (GPC3) in the follicle fluid of women with diminished ovarian reserve (DOR) and to examine the relationship of these markers with the number of embryos and clinical pregnancy. A total of 27 women with DOR and 34 women with normal ovarian reserve who underwent in vitro fertilization procedure were included in this prospectively designed study. Spermidine, Syndecan 1, and GPC3 levels were studied in the follicle fluid samples taken from the women at the time of oocyte retrieval by ELISA method, and their relations with the cycle outcomes were examined. The mean age was found as 38.1 ± 7.4 years in the DOR group and 35.1 ± 5.2 years in the control group (p = 0.027). When adjusted for age and body mass index, while the median Spermidine level was significantly higher (p < 0.001), both Syndecan 1 (p < 0.001) and GPC3 (p = 0.006) were significantly lower in the DOR group compared with control group. The cut-off value of Spermidine for clinical pregnancy prediction was found as 74.08 ng/mL with 78.9% sensitivity and 57.1% specificity [OR: 5 (95% CI: 1.4-17.6); AUC: 0.621; p = 0.138], while it was 0.96 ng/mL with 84.2% sensitivity and 59.5% specificity [OR: 7.8 (95% CI: 2-31.1); AUC: 0.701; p = 0.004] for GP3 and 1.15 ng/mL with 78.9 sensitivity and 57.1% specificity [OR: 5 (95% CI: 1.4-17.6); AUC: 0.680; p = 0.009] for Syndecan 1. Intrafollicular spermidine, Syndecan 1, and GPC3 levels may have a role in ovarian aging. Further randomized controlled studies in a larger population are needed for the relationship of these markers with cycle and pregnancy outcomes.eninfo:eu-repo/semantics/closedAccessDiminished ovarian reserveGlypican 3In vitro fertilizationPregnancySpermidineSyndecan 1Evaluation of intrafollicular syndecan 1, glypican 3, and spermidine levels in women with diminished ovarian reserveArticle10.1007/s43032-022-01085-9302569575Q3WOS:0008559972000012-s2.0-85138363050PMID: 36131221Q2